Dacarbazine EP Impurity A (Monohydrate)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

7151-03-3Dacarbazine EP Impurity A (Monohydrate)

● In Stock

Catalogue No.:VE0022747
CAS No.:7151-03-3
Mol. Formula:C4H3N5O.H2O
Mol. Weight:155.11 g/mol

Additional information on CAS 7151-03-3

Parent drug

Dacarbazine / Temozolomide

IUPAC Name

3, 7-dihydroimidazo[4, 5-d]triazin-4-one;hydrate

Pharmacopoeial Synonyms

Temozolomide EP Impurity E/Dacarbazine Related Compound B (Monohydrate)

Other Synonyms

7H-Imidazo[4, 5-d]-v-triazin-4-one, hydrate;3, 5-dihydroimidazo[4, 5-d]triazin-4-one;hydrate

Smiles

O=C1NN=NC2=C1N=CN2.O

InChI

InChI=1S/C4H3N5O.H2O/c10-4-2-3(6-1-5-2)7-9-8-4;/h1H, (H2, 5, 6, 7, 8, 10);1H2

Description

Dacarbazine EP Impurity A (Monohydrate) also referred to in pharmacopoeias as Temozolomide EP Impurity E/Dacarbazine Related Compound B (Monohydrate) | is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines | including those established by USP | EMA | JP | and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial manufacturing of Dacarbazine / Temozolomide. Furthermore | it is accompanied by a comprehensive Structure Elucidation Report (SER) | ensuring its accuracy and reliability across various analytical applications.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url